AT

Ino Therapeutics Gmbh


USPTO Granted Patents = 36



Trademarks = 19

Forward Citations = 1,617

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Duncan P Bathe (13 out of 38 patents)

silverMedal Frederick John Montgomery (13 out of 35 patents)

bronzeMedal John Klaus (7 out of 23 patents)

4 David Christensen (5 out of 10 patents)

5 James Baldassarre (5 out of 10 patents)

6 Daniel Juhyung Lee (4 out of 50 patents)

7 Duncan P L Bathe (4 out of 15 patents)

8 Jaron Matthew Acker (4 out of 75 patents)

9 Thomas Kohlmann (3 out of 20 patents)

10 Ralf Rosskamp (3 out of 3 patents)

11 Christian Krebs (3 out of 4 patents)

12 Nicholas S Reback (3 out of 27 patents)

13 Craig Flanagan (2 out of 15 patents)

14 Sarah Jayne Ridley (2 out of 4 patents)

15 Simon Freed (2 out of 8 patents)


36 patents:

INO Therapeutics GmbH is a leading pharmaceutical company specializing in the development and manufacture of inhaled nitric oxide (INO) therapies. INO Therapeutics GmbH is dedicated to improving the lives of patients with serious and life-threatening conditions by providing innovative and effective treatment options. With a focus on research and development, INO Therapeutics GmbH aims to advance the use of inhaled nitric oxide in respiratory and cardiovascular diseases. For more information, visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
36 Patents

#6 in

#102 in Austria

#18,177 in the World

...
AT
Forward Citations = 1,617

34 inventors:

Please report any incorrect information to support@idiyas.com
Loading…